Researchers have conducted a comprehensive meta-analysis of available treatments for attention deficit hyperactivity disorder (ADHD) in adults, concluding that only stimulants and atomoxetine are effective at reducing core symptoms.
The study, which analyzed 113 randomized controlled trials involving nearly 15,000 adults with ADHD, found that atomoxetine was less acceptable to patients compared to other treatment options. Non-pharmacological strategies, such as cognitive behavioral therapy, showed inconsistent results in terms of efficacy.
Data on the long-term efficacy of ADHD therapies is limited, and the study’s findings only apply to short-term efficacy. Experts emphasize the need for better evidence to fully understand the effects of non-pharmacological interventions.
According to Dr. Samuele Cortese, a co-investigator on the study, the results provide reassurance about the role of medication as a treatment for ADHD. The study also highlights the potential benefits of non-pharmacological interventions, but notes that more research is needed to establish their efficacy.
The analysis was developed with input from individuals with ADHD and involved a range of treatments, including pharmacological and non-pharmacological options. However, the majority of studies included in the analysis focused on pharmaceutical treatments, which may impact the findings.
While some experts have praised the study’s contribution to the literature, others note that more research is needed to establish the efficacy of neurostimulation therapies for ADHD. Overall, the study provides valuable insights into the most effective treatment options for adult ADHD and highlights the need for further research in this area.
Source: https://www.medscape.com/viewarticle/most-effective-treatments-adult-adhd-identified-2024a1000nf5